Celerus Diagnostics Launches Rapid Diagnostic Tool

DENVER--(BUSINESS WIRE)--Celerus Diagnostics, the rapid cancer diagnostics company, today announced the launch of its revolutionary new system, the WaveTM, at the United States and Canada Academy of Pathology (USCAP) meeting. Capable of producing immunohistochemistry (IHC) results in as little as 15 minutes, the WaveTM System will accelerate lab throughput, enable intra-operative testing, and provide real-time pathology to requesting physicians.